Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
ceo
congress
2
×
detroit blog main
detroit top stories
life sciences
2
×
national
national blog main
2
×
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
2
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
senate
2
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adalimumab
administration
advaxis
aimmune therapeutics
albert bourla
alder biopharmaceuticals
alexander hardy
andrew oxtoby
astrazeneca
babies
biosimilar
What
away
big
bio
bosley's
bosley’s
bridge
bringing
bucks
cas
ceo
ceos
crime
crispr
dc
departure
drug
editas
executives
exit
gathered
groups
guiding
hearing
held
katrine
lower
medicine
moves
personnel
pharma
pharmaceutical
prices
rebates
roundup
senate
seven
surprising
today
washington
week
Language
Current search:
congress
×
senate
×
" national blog main "
×
" life sciences "
×
" san diego top stories "
×
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More